The Role of Thallium-201 Single Photon Emission Tomography in the Investigation and Characterisation of Brain Tumours in Man and Their Response to Treatment

Overview

Journal Eur J Nucl Med

Specialty Nuclear Medicine

Date 1993 Jan 1

PMID 8420781

Citations 19

Authors

Y Yoshii

M Satou

T Yamamoto

Y Yamada

A Hyodo

T Nose

H Ishikawa

R Hatakeyama

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to characterise brain tumour type and treatment response in relation to the uptake of thallium-201. 201T1 single photon emission tomography (SPET) was performed in 58 patients with brain tumours. Fifty-six patients were utilised for the statistical comparison of the early and delayed 201T1 indices expressed as the ratio of tumour to contralateral cerebral hemisphere uptake. The retention index of 201T1 in the tumour tissue calculated from the early and delayed scans was also analysed. Furthermore, in 56 patients with 58 brain tumours, a comparison was made of the diagnostic value of high 201T1 uptake and gadolinium diethylene triamine penta-acetic acid (Gd-DTPA) enhancement on MRI scans. Although high 201T1 uptake was observed in viable malignant gliomas, brain metastases, meningiomas and malignant teratoma, the viable malignant gliomas could not be differentiated from brain metastases and extracerebral tumours by means of 201T1 indices. 201T1 SPET failed to diagnose a viable ring-enhanced tumour with a thin rim and small tumours of less than 1.5 cm in diameter visualised by Gd-DTPA-enhanced MRI. In spite of this, 201T1 SPET appears to be effective for determination of the malignant viability of tumours.

Citing Articles

Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.

Yamauchi M, Okada T, Okada T, Yamamoto A, Fushimi Y, Arakawa Y Medicine (Baltimore). 2017; 96(33):e7767.

PMID: 28816956 PMC: 5571693. DOI: 10.1097/MD.0000000000007767.

Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?.

Amin A, Mustafa M, Abd El-Hadi E, Monier A, Badwey A, Saad E J Neurooncol. 2014; 121(2):303-9.

PMID: 25349131 DOI: 10.1007/s11060-014-1633-9.

Application of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tumor response to gamma knife radiosurgery.

Lee C, Wintermark M, Xu Z, Yen C, Schlesinger D, Sheehan J J Neurooncol. 2014; 118(2):351-361.

PMID: 24760414 DOI: 10.1007/s11060-014-1439-9.

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?.

Shah A, Snelling B, Bregy A, Patel P, Tememe D, Bhatia R J Neurooncol. 2013; 112(2):141-52.

PMID: 23344789 DOI: 10.1007/s11060-013-1059-9.

Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Verma N, Cowperthwaite M, Burnett M, Markey M Neuro Oncol. 2013; 15(5):515-34.

PMID: 23325863 PMC: 3635510. DOI: 10.1093/neuonc/nos307.

References

Marks J, Gado M . Serial computed tomography of primary brain tumors following surgery, irradiation, and chemotherapy. Radiology. 1977; 125(1):119-25. DOI: 10.1148/125.1.119. View

Kim K, Black K, Marciano D, Mazziotta J, Guze B, Grafton S . Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med. 1990; 31(6):965-9. View

Kaplan W, Takvorian T, Morris J, RUMBAUGH C, Connolly B, Atkins H . Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med. 1987; 28(1):47-52. View

Hiesiger E, Fowler J, Wolf A, Logan J, BRODIE J, McPherson D . Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose. J Nucl Med. 1987; 28(8):1251-61. View

Kosuda S, Shioyama Y, Kamata N, Suzuki K, Tanaka Y, Nakamura O . [Differential diagnosis between recurrence of brain tumor and radiation necrosis by 201Tl SPECT]. Nihon Igaku Hoshasen Gakkai Zasshi. 1991; 51(4):415-21. View

Salvatore M, Carratu L, Porta E . Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology. 1976; 121(2):487-8. DOI: 10.1148/121.2.487. View

DI CHIRO G, DelaPaz R, Brooks R, Sokoloff L, KORNBLITH P, Smith B . Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 1982; 32(12):1323-9. DOI: 10.1212/wnl.32.12.1323. View

KASAROV L, Friedman H . Enhanced Na+-K+-activated adenosine triphosphatase activity in transformed fibroblasts. Cancer Res. 1974; 34(8):1862-5. View

Ogawa T, Uemura K, Shishido F, Yamaguchi T, Murakami M, Inugami A . Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study. J Comput Assist Tomogr. 1988; 12(2):290-7. DOI: 10.1097/00004728-198803000-00019. View

10.

Ancri D, Basset J . Diagnosis of cerebral metastases by thallium 201. Br J Radiol. 1980; 53(629):443-53. DOI: 10.1259/0007-1285-53-629-443. View

11.

GEHRING P, HAMMOND P . The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther. 1967; 155(1):187-201. View

12.

Elligsen J, Thompson J, Frey H, Kruuv J . Correlation of (Na+--K+)-ATPase activity with growth of normal and transformed cells. Exp Cell Res. 1974; 87(2):233-40. DOI: 10.1016/0014-4827(74)90475-3. View

13.

Mountz J, McKeever P, Taren J, BEIERWALTES W . Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg. 1988; 68(5):705-9. DOI: 10.3171/jns.1988.68.5.0705. View

14.

Ancri D, Basset J, Lonchampt M, Etavard C . Diagnosis of cerebral lesions by Thallium 201. Radiology. 1978; 128(2):417-22. DOI: 10.1148/128.2.417. View

15.

Langen K, Coenen H, Roosen N, Kling P, Muzik O, Herzog H . SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. J Nucl Med. 1990; 31(3):281-6. View